![]() Urocortin III (human) trifluoroacetate salt structure
|
Common Name | Urocortin III (human) trifluoroacetate salt | ||
---|---|---|---|---|
CAS Number | 357952-09-1 | Molecular Weight | N/A | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C185H307N53O50S2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Urocortin III (human) trifluoroacetate saltUrocortin III (human) is a corticotropin-releasing factor (CRF)-related peptide. Urocortin III (human) preferentially binds and activates CRF-R2 and has a discrete central nervous system and peripheral distribution. Urocortin III (human) selectively binds to type 2 CRF receptors with Ki values of 13.5, 21.7, and >100 nM for mCRF2β, rCRF2α, and hCRF1, respectively. Urocortin III (human) mediates somatostatin-dependent negative feedback control of Insulin (human) (HY-P0035) secretion[1][2]. |
Name | Urocortin III, human |
---|
Description | Urocortin III (human) is a corticotropin-releasing factor (CRF)-related peptide. Urocortin III (human) preferentially binds and activates CRF-R2 and has a discrete central nervous system and peripheral distribution. Urocortin III (human) selectively binds to type 2 CRF receptors with Ki values of 13.5, 21.7, and >100 nM for mCRF2β, rCRF2α, and hCRF1, respectively. Urocortin III (human) mediates somatostatin-dependent negative feedback control of Insulin (human) (HY-P0035) secretion[1][2]. |
---|---|
Related Catalog | |
Target |
Ki: 13.5 (mCRF2β), 21.7 (rCRF2α), and >100 nM ( hCRF1)[1] |
In Vitro | Urocortin III (human) (20 分钟;稳定表达克隆人 CRF-R1 或鼠 CRF-R2 的 CHO 细胞) 诱导细胞内 cAMP 积累[1]。 |
References |
Molecular Formula | C185H307N53O50S2 |
---|